At the end of the latest market close, Abbott Laboratories (ABT) was valued at $107.53. In that particular session, Stock kicked-off at the price of $107.08 while reaching the peak value of $108.27 and lowest value recorded on the day was $106.93. The stock current value is $107.90.
Recently in News on December 2, 2020, Abbott’s FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms. – FreeStyle Libre 2 system continuously measures glucose data every minute with customizable, optional real-time alarms1 to alert users when their glucose is high or low without scanning. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Abbott Laboratories had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $115.14 on 11/06/20, with the lowest value was $61.61 for the same time period, recorded on 03/23/20.
Abbott Laboratories (ABT) full year performance was 26.58%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Abbott Laboratories shares are logging -6.29% during the 52-week period from high price, and 75.13% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $61.61 and $115.14.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4673461 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Abbott Laboratories (ABT) recorded performance in the market was 24.22%, having the revenues showcasing 3.59% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 190.58B, as it employees total of 107000 workers.
Market experts do have their say about Abbott Laboratories (ABT)
During the last month, 0 analysts gave the Abbott Laboratories a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 105.77, with a change in the price was noted +11.17. In a similar fashion, Abbott Laboratories posted a movement of +11.55% for the period of last 100 days, recording 5,174,301 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ABT is recording 0.59 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.58.
Technical breakdown of Abbott Laboratories (ABT)
Raw Stochastic average of Abbott Laboratories in the period of last 50 days is set at 51.08%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 23.87%. In the last 20 days, the company’s Stochastic %K was 23.45% and its Stochastic %D was recorded 25.63%.
Bearing in mind the latest performance of Abbott Laboratories, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 24.22%. Additionally, trading for the stock in the period of the last six months notably improved by 16.57%, alongside a boost of 26.58% for the period of the last 12 months. The shares increased approximately by 0.26% in the 7-day charts and went up by -3.25% in the period of the last 30 days. Common stock shares were driven by 3.59% during last recorded quarter.